Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-α by equine monocytes
- 1 January 2008
- journal article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 121 (1-2) , 91-100
- https://doi.org/10.1016/j.vetimm.2007.08.011
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Pharmacologic characterization of novel adenosine A2A receptor agonists in equine neutrophilsAmerican Journal of Veterinary Research, 2007
- Effects of stimulation of adenosine A2A receptors on lipopolysaccharide-induced production of reactive oxygen species by equine neutrophilsAmerican Journal of Veterinary Research, 2007
- Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activatedBritish Journal of Pharmacology, 2007
- Cloning and pharmacological characterization of the equine adenosine A2A receptor: a potential therapeutic target for the treatment of equine endotoxemiaJournal of Veterinary Pharmacology and Therapeutics, 2006
- Cloning and pharmacological characterization of the equine adenosine A3receptorJournal of Veterinary Pharmacology and Therapeutics, 2006
- Adenosine receptor signaling in the brain immune systemTrends in Pharmacological Sciences, 2005
- Adenosine A2Aagonists in development for the treatment of inflammationExpert Opinion on Investigational Drugs, 2005
- Adenosine: an endogenous regulator of innate immunityTrends in Immunology, 2004
- Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue ProtectionAnnual Review of Pharmacology and Toxicology, 2001
- Endotoxemia in Horses: A Review of Cellular and Humoral Mediators Involved in its PathogenesisJournal of Veterinary Internal Medicine, 1991